Literature DB >> 8157701

Health care expenditures for people with diabetes mellitus, 1992.

R J Rubin1, W M Altman, D N Mendelson.   

Abstract

The purpose of this report is to estimate diabetes prevalence and annual health care costs for people with diabetes in 1992, compare average annual costs for diabetics and nondiabetics, and estimate the portion of total U.S. health care expenditures incurred by people with the disease. Data from the 1987 National Medical Expenditure Survey were used to estimate diabetes prevalence and health care expenditures for diabetics in 1992. Diabetics were identified based on self-reports of a physician diagnosis of diabetes, a history of taking diabetic medications, or an encounter with the health care system specifically related to diabetes. Identified diabetics were classified as confirmed if they had a history of taking diabetic medications, had a diabetes-specific encounter with the health care system, or purchased diabetic equipment. Estimates of diabetes prevalence and health care expenditures were calculated separately for identified and confirmed diabetics using the National Medical Expenditure Survey database. Total health care expenditures included costs associated with inpatient hospital care, outpatient hospital care, office visits to a physician or other provider, emergency room visits, home health care, prescription drugs, dental care, and durable medical equipment purchases. We estimate that percapita annual health care expenditures in 1992 were more than three times greater for diabetics ($9,493) than for nondiabetics ($2,604). Percapita expenditures for confirmed diabetics ($11,157) were more than four times greater than for nondiabetics. In 1992, diabetics constituted 4.5% of the U.S. population but accounted for 14.6% of total U.S. health care expenditures ($105 billion). Confirmed diabetics constituted 3.1% of the U.S. population but accounted for 11.9% of total U.S. health care expenditures ($85 billion). This study found that health care expenditures for people with diabetes constituted about one in seven health care dollars spent in 1992. Health care reform and insurers should take note of these findings and structure benefit packages to promote care likely to reduce the costs of caring for diabetics.

Entities:  

Mesh:

Year:  1994        PMID: 8157701     DOI: 10.1210/jcem.78.4.8157701

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  39 in total

1.  Costs of diabetes. A methodological analysis of the literature.

Authors:  E Pagano; M Brunetti; F Tediosi; L Garattini
Journal:  Pharmacoeconomics       Date:  1999-06       Impact factor: 4.981

Review 2.  Cost-effective management of diabetic foot ulcers. A review.

Authors:  G Ragnarson-Tennvall; J Apelqvist
Journal:  Pharmacoeconomics       Date:  1997-07       Impact factor: 4.981

3.  The cost burden of diabetes mellitus: the evidence from Germany--the CoDiM study.

Authors:  I Köster; L von Ferber; P Ihle; I Schubert; H Hauner
Journal:  Diabetologia       Date:  2006-05-11       Impact factor: 10.122

4.  Are ethnic differences in insulin sensitivity explained by variation in carbohydrate intake?

Authors:  V A Diaz; A G Mainous; R J Koopman; M E Geesey
Journal:  Diabetologia       Date:  2005-04-28       Impact factor: 10.122

Review 5.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.

Authors:  Yan Zheng; Sylvia H Ley; Frank B Hu
Journal:  Nat Rev Endocrinol       Date:  2017-12-08       Impact factor: 43.330

6.  American ginseng berry juice intake reduces blood glucose and body weight in ob/ob mice.

Authors:  J T Xie; C Z Wang; M Ni; J A Wu; S R Mehendale; H H Aung; A Foo; C S Yuan
Journal:  J Food Sci       Date:  2007-10       Impact factor: 3.167

Review 7.  Obesity and sedentary lifestyle: modifiable risk factors for prevention of type 2 diabetes.

Authors:  E J Mayer-Davis; T Costacou
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

8.  Race, rural residence, and control of diabetes and hypertension.

Authors:  Arch G Mainous; Dana E King; David R Garr; William S Pearson
Journal:  Ann Fam Med       Date:  2004 Nov-Dec       Impact factor: 5.166

9.  Examining the economic costs related to lifestyle and pharmacological interventions in youth with Type 2 diabetes.

Authors:  Thomas Songer; Judith Glazner; Laura P Coombs; Leona Cuttler; Mary Daniel; Silvia Estrada; Georgeanna Klingensmith; Andrea Kriska; Lori Laffel; Ping Zhang
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2006-06-01       Impact factor: 2.217

10.  Revealing the cost of Type II diabetes in Europe.

Authors:  B Jönsson
Journal:  Diabetologia       Date:  2002-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.